Ensemble Therapeutics today announced that preclinical data showing the
advantages of its Ensemblins, novel macrocyclic compounds against
challenging drug targets, will be presented at the 245th American
... read more
Ensemble Therapeutics today announced that preclinical data showing the
advantages of novel macrocyclic compounds against challenging drug
targets, including its first-in-class, orally active small molecule
... read more